Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G.

Am J Kidney Dis. 2008 Sep;52(3):454-63. doi: 10.1053/j.ajkd.2008.01.025. Epub 2008 Apr 22. Review.

PMID:
18433957
2.

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.

Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.

Am J Kidney Dis. 2009 Apr;53(4):606-16. doi: 10.1053/j.ajkd.2008.11.026. Epub 2009 Feb 12.

PMID:
19216016
3.

Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ.

Am J Kidney Dis. 2008 Sep;52(3):464-74. doi: 10.1053/j.ajkd.2008.05.012. Epub 2008 Jul 9.

PMID:
18617301
4.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
5.

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.

Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12.

PMID:
18468748
6.

Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.

Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.

Ren Fail. 2010 Jan;32(2):172-8. doi: 10.3109/08860221003602645.

PMID:
20199178
8.

Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis.

Tian ML, Shen Y, Sun ZL, Zha Y.

Int Urol Nephrol. 2015 May;47(5):815-22. doi: 10.1007/s11255-015-0968-2. Epub 2015 Apr 11. Review.

PMID:
25862237
9.

Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.

Jiang X, Zhou S, Yao J, Kong X, Cui M.

J Nephrol. 2016 Oct;29(5):653-62. doi: 10.1007/s40620-015-0240-y. Epub 2015 Oct 28. Review.

PMID:
26510426
10.

Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

Renke M, Tylicki L, Rutkowski P, Knap N, Zietkiewicz M, Neuwelt A, Aleksandrowicz E, Łysiak-Szydłowska W, Woźniak M, Rutkowski B.

Acta Biochim Pol. 2010;57(1):119-23. Epub 2010 Mar 22.

11.

A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.

Sinsakul M, Sika M, Rodby R, Middleton J, Shyr Y, Chen H, Han E, Lehrich R, Clyne S, Schulman G, Harris R, Lewis J.

Am J Kidney Dis. 2007 Dec;50(6):946-51.

PMID:
18037095
12.

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.

PMID:
17984482
13.

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis.

Sarafidis PA, Stafylas PC, Georgianos PI, Saratzis AN, Lasaridis AN.

Am J Kidney Dis. 2010 May;55(5):835-47. doi: 10.1053/j.ajkd.2009.11.013. Epub 2010 Jan 29. Review.

PMID:
20110146
14.

The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.

Ghorbani A, Omidvar B, Beladi-Mousavi SS, Lak E, Vaziri S.

Nefrologia. 2012;32(6):790-6. doi: 10.3265/Nefrologia.pre2012.Jun.11242.

15.
17.

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.

Guerrero-Romero F, Rodríguez-Morán M, Paniagua-Sierra JR, García-Bulnes G, Salas-Ramírez M, Amato D.

Clin Nephrol. 1995 Feb;43(2):116-21.

PMID:
7736673
18.

The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.

de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D.

J Cardiovasc Pharmacol. 1992;19 Suppl 6:S28-32. Review.

PMID:
1382162
19.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2015 Jun 4;(6):CD009191. doi: 10.1002/14651858.CD009191.pub3. Review.

PMID:
26041152
20.

Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.

Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.

Am Heart J. 2008 May;155(5):791-805. doi: 10.1016/j.ahj.2008.01.031. Erratum in: Am Heart J. 2009 Mar;157(3):501. Jalandara, Nishant [corrected to Jalandhara, Nishant].

PMID:
18440325

Supplemental Content

Support Center